Immunovant (IMVT) Shares Outstanding (2018 - 2026)
Immunovant (IMVT) reported Shares Outstanding of 205.55 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 20.3% from 170.87 million a year earlier and up 12.7% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Shares Outstanding (2018 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Immunovant posted Shares Outstanding of 182.42 million, up 20.4% from FY2025.
- Shares Outstanding has increased for seven consecutive fiscal years, with a five-year compound annual growth rate of 15.8% (FY2021 to FY2026).
- By fiscal year, Shares Outstanding came in at 151.57 million in FY2025 (+9.8%), 138.1 million in FY2024 (+12.2%), 123.08 million in FY2023 (+12.2%) and 109.68 million in FY2022 (+25.0%).
- The fiscal Q1 2027 figure ranks as the highest quarterly Shares Outstanding in data going back to fiscal Q3 2019.
- Year over year, Shares Outstanding has now increased in each of the last 27 quarters, with growth averaging 15.3% over the last eight quarters.
- The year-over-year growth in Shares Outstanding has ranged between 1.7% (fiscal Q3 2025) and 29.3% (fiscal Q2 2022) over the last five years.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at 182.42 million (Q4 2026), 181.51 million (Q3 2026) and 173.64 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Immunovant | 6.97 Bn | 6.97 Bn | - | 205.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 205.55 Mn |
| Mar 31, 2026 | 182.42 Mn |
| Dec 31, 2025 | 181.51 Mn |
| Sep 30, 2025 | 173.64 Mn |
| Jun 30, 2025 | 170.87 Mn |
| Mar 31, 2025 | 151.57 Mn |
| Dec 31, 2024 | 146.92 Mn |
| Sep 30, 2024 | 146.47 Mn |
| Jun 30, 2024 | 146.09 Mn |
| Mar 31, 2024 | 138.10 Mn |
| Dec 31, 2023 | 144.52 Mn |
| Sep 30, 2023 | 131.16 Mn |
| Jun 30, 2023 | 130.50 Mn |
| Mar 31, 2023 | 123.08 Mn |
| Dec 31, 2022 | 128.57 Mn |
| Sep 30, 2022 | 116.57 Mn |
| Jun 30, 2022 | 116.56 Mn |
| Mar 31, 2022 | 109.68 Mn |
| Dec 31, 2021 | 115.03 Mn |
| Sep 30, 2021 | 109.08 Mn |
API Access
Immunovant Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();